Paper7003392
Calcitonin: physiology and pathophysiology.
Austin LA and 1 other. N Engl J Med, 1981. Cited by 384 papers, by iCite.
Cite this record
ConductScience Library. Calcitonin: physiology and pathophysiology. Papers, record 7003392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7003392
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcitonin | Major topic |
| Animals | |
| Bone and Bones | |
| Calcium | |
| Digestive System | |
| Humans | |
| Hypercalcemia | |
| Kidney | |
| Male | |
| Neoplasms | |
| Osteitis Deformans | |
| Sex Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AM 19607 | NIADDK NIH HHS | United States | R01AM019607 | PubMed and NIH | NIH RePORTER |
| AM 21101 | NIADDK NIH HHS | United States | R01AM021101 | PubMed and NIH | NIH RePORTER |
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 384 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40102257 | Calcitonin as Biomarker for the Medullary Thyroid Carcinoma. | Recent Results Cancer Res | 2025 | https://conductscience.org/library/papers/40102257 | PubMed |
| 40095491 | Circulating Biomarkers of Thyroid Cancer: An Appraisal. | J Clin Med | 2025 | https://conductscience.org/library/papers/40095491 | PubMed |
| 39863860 | Endogenous peptide CBDP1 inhibits clear cell renal cell carcinoma progression by targeting USP5/YTHDF2/TRPM5 axis. | J Transl Med | 2025 | https://conductscience.org/library/papers/39863860 | PubMed |
| 39156946 | Survival Outcomes in Malignancy-related Hypercalcemia: A Tertiary Care Single-center Experience. | J Cancer Allied Spec | 2024 | https://conductscience.org/library/papers/39156946 | PubMed |
| 38501491 | Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations. | Protein Sci | 2024 | https://conductscience.org/library/papers/38501491 | PubMed |
| 38014394 | Computation meets experiment: identification of highly efficient fibrillating peptides. | CrystEngComm | 2023 | https://conductscience.org/library/papers/38014394 | PubMed |
| 37354016 | Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments. | Protein Sci | 2023 | https://conductscience.org/library/papers/37354016 | PubMed |
| 37033238 | Cancer-related hypercalcemia and potential treatments. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37033238 | PubMed |
| 35682830 | Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682830 | PubMed |
| 34410575 | COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells. | Immunol Res | 2021 | https://conductscience.org/library/papers/34410575 | PubMed |
| 34121973 | Diabetoporosis: Role of nitric oxide. | EXCLI J | 2021 | https://conductscience.org/library/papers/34121973 | PubMed |
| 33015068 | Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33015068 | PubMed |
| 29947178 | Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. | Endocrinol Metab (Seoul) | 2018 | https://conductscience.org/library/papers/29947178 | PubMed |
| 29713033 | Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent. | Nat Chem | 2018 | https://conductscience.org/library/papers/29713033 | PubMed |
| 29181551 | [Metabolic disorders as paraneoplastic syndromes]. | Internist (Berl) | 2018 | https://conductscience.org/library/papers/29181551 | PubMed |
| 28689769 | Osteoporosis treatment: recent developments and ongoing challenges. | Lancet Diabetes Endocrinol | 2017 | https://conductscience.org/library/papers/28689769 | PubMed |
| 26713296 | Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. | N Am J Med Sci | 2015 | https://conductscience.org/library/papers/26713296 | PubMed |
| 26664216 | Unmasking of primary hyperparathyroidism by Vitamin D therapy. | Indian J Nephrol | 2015 | https://conductscience.org/library/papers/26664216 | PubMed |
| 26424367 | Oncological emergencies associated with gastrointestinal tumors. | Ann Gastroenterol | 2015 | https://conductscience.org/library/papers/26424367 | PubMed |
| 23934479 | [Tumor-induced hypercalcemia]. | Internist (Berl) | 2013 | https://conductscience.org/library/papers/23934479 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CALCA | 796 | PubTator's text mining | https://conductscience.org/library/genes/796 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7003392
GET https://conductscience.org/api/papers/v1/7003392/cited_by?page=2